Page 169 - Ghidul Serviciilor Medicale Synevo, Ediția 2, Volum 3

GHIDUL SERVICIILOR MEDICALE 18
AL LABORATOARELOR SYNEVO TESTE DE BIOLOGIE MOLECULARĂ

phenotype. In Journal of Cancer 98:502 – 507, 2008.
4. B Xu, N Tong, J-m Li, Z-d Zhang and H-f Wu. ELAC2 polymorphisms and prostate cancer risk:
a meta-analysis based on 18 case–control studies, Prostate Cancer and Prostatic Diseases,
13:270–277, 2010.
5. Daniel J. Schaid. The complex genetic epidemiology of prostate cancer. In Human Molecular
Genetics, 13:R103–R121, 2004.
6. Fredrik Wiklund, Björn-Anders Jonsson, Anthony J. Brookes, Linda Strömqvist, Jan Adolfsson,
Monica Emanuelsson, Hans-Olov Adami, Katarina Augustsson-Bälter,and Henrik Grönberg.
Genetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer. In
Clinical Cancer Research, 10:7150–7156, 2004.
7. Huihua Liand Bee ChooTai. RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a
Meta- analysis. In Clin Cancer Res, 12:5713, 2006.
8. Jun Li, Ralph J. Coates, Marta Gwinn, and Muin J. Khoury, Steroid 5-a-Reductase Type 2
(SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review. In Am J
Epidemiol, 171:1–13, 2010.
9. L.E. Johns and R.S. Houlston. A systematic review and meta-analysis of familial prostate
cancer risk. In BJU International, 91:789– 794
10. Laborator Synevo. Referinţele specifice tehnologiei de lucru utilizate 2010. Ref Type: Catalog.
11. Ola Bratt, Hereditary prostate cancer: clinical aspects. In The Journal Of Urology, 168:906–
913, 2002

169